Litigation for EMPAGLIFLOZIN; LINAGLIPTIN
✉ Email this page to a colleague
US Court Litigation for EMPAGLIFLOZIN; LINAGLIPTIN
| Patent | Case Name | Docket | Date Filed | Date Terminated | Cause | Court | Jury Demand | Link To Docket |
|---|---|---|---|---|---|---|---|---|
| 10,258,637 | ⤷ Subscribe | ⤷ Subscribe | 2018-10-26 | 35:271 Patent Infringement | District Court, D. Delaware | None | ⤷ Subscribe | |
| 10,258,637 | Boehringer Ingelheim Pharmaceuticals Inc. v. Lupin Ltd. | ⤷ Subscribe | 2018-10-26 | 35:271 Patent Infringement | District Court, D. Delaware | None | ⤷ Subscribe | |
| 10,258,637 | ⤷ Subscribe | ⤷ Subscribe | 2019-07-11 | 35:271 Patent Infringement | District Court, D. Delaware | None | ⤷ Subscribe | |
| 10,258,637 | ⤷ Subscribe | ⤷ Subscribe | 2019-08-28 | 35:271 Patent Infringement | District Court, D. Delaware | None | ⤷ Subscribe | |
| >Patent | >Case Name | >Docket | >Date Filed | >Date Terminated | >Cause | >Court | >Jury Demand | >Link To Docket |
Patent Trial and Appeal Board Cases for EMPAGLIFLOZIN; LINAGLIPTIN
| Patent | Petitioner | Status | Filing Date | Accorded Filing Date | Patent Owner | Trial Type | Trial Number | Decision Date | Inventor | Document Download |
|---|---|---|---|---|---|---|---|---|---|---|
| 8,673,927 | Mylan Pharmaceuticals Inc. et al. | ⤷ Subscribe | 2016-08-10 | 08-10-2016 | DUGI et al | Inter partes review | ⤷ Subscribe | 02-03-2017 | ⤷ Subscribe | |
| 8,846,695 | Mylan Pharmaceuticals Inc. et al. | ⤷ Subscribe | 2016-08-10 | 08-10-2016 | Dugi | Inter partes review | ⤷ Subscribe | 01-31-2017 | ⤷ Subscribe | |
| 9,173,859 | Mylan Pharmaceuticals Inc. et al. | ⤷ Subscribe | 2016-08-10 | 08-10-2016 | DUGI et al | Inter partes review | ⤷ Subscribe | 02-03-2017 | ⤷ Subscribe | |
| >Patent | >Petitioner | >Status | >Filing Date | >Accorded Filing Date | >Patent Owner | >Trial Type | >Trial Number | >Decision Date | >Inventor | >Document Download |
